日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study

波尼西莫德治疗复发型多发性硬化症患者的长期安全性和有效性:来自 3 期 OPTIMUM 5 年长期扩展研究的结果

Montalban, Xavier; Hohlfeld, Reinhard; Pozzilli, Carlo; Freedman, Mark S; Sprenger, Till; Fox, Robert J; Havrdova, Eva Kubala; Lublin, Fred; Huang, Dan; Raghavan, Nandini; Wong, Janice; Vaclavkova, Andrea; Dukovski, Jelena; Linscheid, Philippe; Burcklen, Michel; Kappos, Ludwig

Evaluation of cortical pathology in primary-progressive multiple sclerosis: a post hoc analysis of the SPRINT-MS trial

原发性进展型多发性硬化症皮质病理学评估:SPRINT-MS试验的事后分析

Krijnen, Eva A; Bruijn, Anne M; Eloyan, Ani; Schoonheim, Menno M; Fox, Robert J; Klawiter, Eric C

Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis

新冠病毒感染对多发性硬化症症状严重程度和残疾的影响

Salter, Amber; Lancia, Samantha; Cutter, Gary R; Fox, Robert J; Marrie, Ruth Ann

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study

在复发型多发性硬化症进展期患者中,从其他疾病修饰疗法转换为西尼莫德治疗的安全性和耐受性:EXCHANGE 研究的结果

Fox, Robert J; Cohan, Stanley; Mao-Draayer, Yang; Weinstock-Guttman, Bianca; Cruz, Linda-Ali; Arnould, Sophie; Cox, Gina Mavrikis; Bar-Or, Amit

Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis

COVID-19感染后多发性硬化症患者的急性后遗症

Salter, Amber; Lancia, Samantha; Cutter, Gary R; Fox, Robert J; Marrie, Ruth Ann

Automated identification of older adults at risk for cognitive decline

自动识别有认知衰退风险的老年人

Floden, Darlene P; Hogue, Olivia; Saxena, Saket A; Misra-Hebert, Anita D; Milinovich, Alex; Rothberg, Michael B; Pfoh, Elizabeth R; Busch, Robyn M; Krishnan, Kamini; Fox, Robert J; Kattan, Michael W

Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis

多发性硬化症患者的感染、复发和假性复发

Salter, Amber; Lancia, Samantha; Sharma, Mudita; Cutter, Gary R; Fox, Robert J; Marrie, Ruth Ann

Diffusion tensor imaging in the SPRINT-MS clinical trial: Advancing trial methodology

SPRINT-MS临床试验中的弥散张量成像:推进试验方法

Sakaie, Ken; Du, Mengke; Obuchowski, Nancy; Lowe, Mark J; Lin, Jian; Fox, Robert J

Tolebrutinib Phase 2b Long-Term Extension Study: Two-Year Safety, MRI, and Clinical Efficacy Outcomes in Patients With Relapsing Multiple Sclerosis Patients

Tolebrutinib 2b期长期扩展研究:复发型多发性硬化症患者两年安全性、MRI和临床疗效结果

Oh, Jiwon; Fox, Robert J; Arnold, Douglas Lorne; Syed, Sana; Dukovic, Deborah; Vargas, Wendy S; Turner, Timothy J; Underwood, Conor F; Long, Tiha M; Traboulsee, Anthony L; Reich, Daniel S

Disability independent of cerebral white matter demyelination in progressive multiple sclerosis

进行性多发性硬化症中与脑白质脱髓鞘无关的残疾

Singh, Vikas; Zheng, Yufan; Ontaneda, Daniel; Mahajan, Kedar R; Holloman, Jameson; Fox, Robert J; Nakamura, Kunio; Trapp, Bruce D